Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 open-label study of NPC-02 in Wilson's disease
jRCT2080220112Phase 3
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Sep 2005
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of NPC-02 in Wilson disease (WD), sponsored by Nobelpharma Co., Ltd.
02
Drugs
NPC-02
03
Conditions
Wilson disease (WD)
Beyond the preview
Go deeper on jRCT2080220112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220112.